[Abstract] Biofilm formation is a well-known bacterial strategy that protects cells from hostile environments. During infection, bacteria found in a biofilm community are less sensitive to antibiotics and to the immune response, often allowing them to colonize and persist in the host niche. Not surprisingly, biofilm formation on medical devices, such as urinary catheters, is a major problem in hospital settings. To be able to eliminate such biofilms, it is important to understand the key bacterial factors that contribute to their formation. A common practice in the lab setting is to study biofilms grown in laboratory media. However, these media do not fully reflect the host environment conditions, potentially masking relevant biological determinants. This is the case during urinary catheterization, where a key element for Enterococcus faecalis and Staphylococcus aureus colonization and biofilm formation is the release of fibrinogen (Fg) into the bladder and its deposition on the urinary catheter. To recapitulate bladder conditions during catheter-associated urinary tract infection (CAUTI), we have developed a fibrinogen-coated catheter and 96-well plate biofilm assay in urine. Notably, enterococcal biofilm factors identified in these in vitro assays proved to be important for biofilm formation in vivo in a mouse model of CAUTI. Thus, the method described herein can be used to uncover biofilm-promoting factors that are uniquely relevant in the host environment, and that can be exploited to develop new antibacterial therapies.
studies using animal models showed that E. faecalis forms robust biofilms on indwelling urinary catheters, and it was hypothesized that bacterial attachment occurred, at least in part, via Ebp, the endocarditis-and-biofilm-associated pilus (Nielsen et al., 2012) . This hypothesis was substantiated by the finding that ebp deletion mutants were deficient in biofilm formation in vitro (in tryptic soy broth supplemented with 0.25% glucose [TSBG] ) and in vivo, and were highly attenuated in animal models (Singh et The method described (Figure 1 ) herein highlights the importance of developing assays that closely mimic the host environment to be able to study bacterial processes that are critical during infection. This concept is not restricted to the urinary tract or to E. faecalis, as it could be generally applied to studies of bacterial pathophysiology within the vertebrate host, like for example the oral cavity or the cardiovascular system.
Materials and Reagents
A. Bacterial growth and biofilm assay www.bio-protocol.org/e3196 2. Incubate bacteria overnight at 37 °C.
3. Add 10 ml of BHI media into a 15 ml conical tube.
4. Using a sterile inoculation loop, pick a single E. faecalis colony to inoculate the media. 6. Thaw the fibrinogen stock solution at 37 °C, and bring the 1x PBS solution to 37 °C. Fibrinogen is soluble at body temperature; therefore, keep it at 37 °C until you add it to the silicone pieces.
7. Prepare a working solution of 100 µg/ml of fibrinogen in 1x PBS.
8. Add 1 ml of the fibrinogen solution to the test tube containing the silicone piece.
9. Incubate the silicone pieces at 4 °C overnight under static conditions to allow fibrinogen to coat the catheter.
Microplate
10. Dispense 100 µl of the 100 µg/ml fibrinogen solution (Step B7) into each well of the 96-well polystyrene plates (Grenier Bio-One CellSTAR).
11. Seal the plate with a sterile plate sealing tape.
12. Incubate the microplate at 4 °C overnight to allow fibrinogen to coat the bottom of the well.
C. Culture preparation 1. Centrifuge the overnight culture (Step A5) for 10 min at 7,000 rpm (7,505 x g).
2. Remove supernatant.
3. Resuspend the bacterial pellet with 10 ml of 1x PBS solution. Then centrifuge again for 10 min at 7,000 rpm (7,505 x g). Wash the bacterial cells by resuspending the bacterial pellet with 10 ml of 1x PBS solution. Repeat this step 3 times.
4. Dilute 1 ml of bacterial solution into 9 ml of 1x PBS solution (dilution 1:10). This step is necessary to ensure the accuracy of the measurement.
5. Take 1 ml of the diluted solution and put it into a cuvette.
6. Measure optical density (OD600) by using the spectrophotometer.
Note: Multiply the OD600 value by 10 (dilution factor) to obtain the final optical density of the culture.
7. Dilute the culture to a final OD600 of 1.0.
8. Supplement fresh filter-sterilized urine (see Recipe 2) with 20 mg/ml of BSA.
9. Filter sterilize the supplemented urine using bottle top filter. 2. Aspirate the fibrinogen solution gently using a 1,000 µl pipette.
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water. Serial dilution may be required to fall into the linear range of the plate reader.
Data analysis
A. Analysis of biofilm-associated CFU 1. Log10 transform final bacterial counts recovered from each catheter (n ≥ 3) (Figure 3 ).
2. Plot data on a linear scale and include the arithmetic mean. 
Figure 3. Representative data of biofilm measured by colony forming units (CFU).
Comparison of biofilm formation between E. faecalis OG1RF (wild-type strain) and a manganese uptake system triple mutant strain (ΔefaΔmntH1ΔmntH2), which is a biofilm deficient mutant. Two-tailed Mann-Whitney U tests were performed to determine significance between two groups (***P < 0.0002). 
